Gene-ontology enrichment analysis in two independent family-based samples highlights biologically plausible processes for autism spectrum disorders
- PMID: 21522181
- PMCID: PMC3190264
- DOI: 10.1038/ejhg.2011.75
Gene-ontology enrichment analysis in two independent family-based samples highlights biologically plausible processes for autism spectrum disorders
Abstract
Recent genome-wide association studies (GWAS) have implicated a range of genes from discrete biological pathways in the aetiology of autism. However, despite the strong influence of genetic factors, association studies have yet to identify statistically robust, replicated major effect genes or SNPs. We apply the principle of the SNP ratio test methodology described by O'Dushlaine et al to over 2100 families from the Autism Genome Project (AGP). Using a two-stage design we examine association enrichment in 5955 unique gene-ontology classifications across four groupings based on two phenotypic and two ancestral classifications. Based on estimates from simulation we identify excess of association enrichment across all analyses. We observe enrichment in association for sets of genes involved in diverse biological processes, including pyruvate metabolism, transcription factor activation, cell-signalling and cell-cycle regulation. Both genes and processes that show enrichment have previously been examined in autistic disorders and offer biologically plausibility to these findings.
References
-
- Fombonne E. Epidemiology of pervasive developmental disorders. Pediatr Res. 2009;65:591–598. - PubMed
-
- Fernell E, Gillberg C. Autism spectrum disorder diagnoses in Stockholm preschoolers. Res Dev Disabil. 2010;31:680–685. - PubMed
-
- Bailey A, Le Couteur A, Gottesman I, et al. Autism as a strongly genetic disorder: evidence from a British twin study. Psychol Med. 1995;25:63–77. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- P50 HD055782/HD/NICHD NIH HHS/United States
- R01 NS049261/NS/NINDS NIH HHS/United States
- MH066673/MH/NIMH NIH HHS/United States
- NS049261/NS/NINDS NIH HHS/United States
- P01 NS026630/NS/NINDS NIH HHS/United States
- 075491/Z/04/WT_/Wellcome Trust/United Kingdom
- CAPMC/ CIHR/Canada
- NS042165/NS/NINDS NIH HHS/United States
- AS7462/AS/Autism Speaks/United States
- P50 HD055751/HD/NICHD NIH HHS/United States
- P50 HD055784/HD/NICHD NIH HHS/United States
- 090532/WT_/Wellcome Trust/United Kingdom
- MH06359/MH/NIMH NIH HHS/United States
- G0601030/MRC_/Medical Research Council/United Kingdom
- NS026630/NS/NINDS NIH HHS/United States
- U54 MH066673/MH/NIMH NIH HHS/United States
- HD055751/HD/NICHD NIH HHS/United States
- MH55284/MH/NIMH NIH HHS/United States
- MH080647/MH/NIMH NIH HHS/United States
- MH061009/MH/NIMH NIH HHS/United States
- HD055782/HD/NICHD NIH HHS/United States
- R01 MH061009/MH/NIMH NIH HHS/United States
- MH081754/MH/NIMH NIH HHS/United States
- U10 MH066766/MH/NIMH NIH HHS/United States
- R01 NS042165/NS/NINDS NIH HHS/United States
- MH66766/MH/NIMH NIH HHS/United States
- MH52708/MH/NIMH NIH HHS/United States
- R01 MH080647/MH/NIMH NIH HHS/United States
- HD055784/HD/NICHD NIH HHS/United States
- R01 MH081754/MH/NIMH NIH HHS/United States
- R01 MH055284/MH/NIMH NIH HHS/United States
LinkOut - more resources
Full Text Sources